MAIA Biotechnology (MAIA) Common Equity (2021 - 2026)
MAIA Biotechnology (MAIA) posted Common Equity of $20.68 million for Q2 2026, up 433.3% from $3.88 million a year earlier but down 25.5% from the prior quarter.
Powered by 
Analysis
MAIA Biotechnology (MAIA) Common Equity (2021 - 2026) Analysis & Trends
At the end of FY2025, MAIA Biotechnology's Common Equity came in at $2.38 million, down 34.6% from FY2024.
- Annual Common Equity shows a four-year compound annual growth rate of -28.7% (FY2021 to FY2025).
- In prior years, MAIA Biotechnology's Common Equity was $3.63 million in FY2024 (+661.2%), $477,511 in FY2023 (-94.4%), $8.51 million in FY2022 (-7.3%) and $9.18 million in FY2021.
- Quarterly Common Equity has run from a low of -$5.76 million in Q1 2024 to a high of $27.76 million in Q1 2026 over five years.
- On a year-over-year basis, Common Equity increased in four of the last seven quarters, with growth averaging 200.8%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2024, with growth of 661.2%; the weakest was Q3 2025, with a decline of 97.4%.
- According to Business Quant data, Common Equity for the three prior quarters was $27.76 million (Q1 2026), $2.38 million (Q4 2025) and $41,670 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | MAIA Biotechnology | 69.31 Mn | -12.25 Mn | - | 20.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.68 Mn |
| Mar 31, 2026 | 27.76 Mn |
| Dec 31, 2025 | 2.38 Mn |
| Sep 30, 2025 | 41,670.00 |
| Jun 30, 2025 | 3.88 Mn |
| Mar 31, 2025 | 4.94 Mn |
| Dec 31, 2024 | 3.63 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 3.16 Mn |
| Mar 31, 2024 | -5.76 Mn |
| Dec 31, 2023 | 477,511.00 |
| Sep 30, 2023 | 2.75 Mn |
| Jun 30, 2023 | 6.87 Mn |
| Mar 31, 2023 | 5.08 Mn |
| Dec 31, 2022 | 8.51 Mn |
| Sep 30, 2022 | 12.11 Mn |
| Jun 30, 2022 | 6.66 Mn |
| Mar 31, 2022 | 9.01 Mn |
| Dec 31, 2021 | 9.18 Mn |
| Sep 30, 2021 | 10.23 Mn |
API Access
MAIA Biotechnology Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MAIA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MAIA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MAIA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();